Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03836989
Other study ID # 16901
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date January 22, 2018
Est. completion date August 31, 2020

Study information

Verified date May 2021
Source Oregon Health and Science University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A feasibility pilot study to exam the necessary methodology for conducting a larger clinical trial for Bell's Palsy patients with a poor prognosis and the use of electrical stimulation.


Description:

Here we describe a protocol for a prospective, randomized, double-blinded study to evaluate the effects of monophasic pulsed current ES on patients with Bell's palsy and factors predicting poor recovery, with a 6 month follow up. Motor level stimulation with a pulse duration of 100 μsec and a frequency of 35 pulses per second were chosen from focus group with physical therapist to treat facial paralysis and are consistent with clinical trials showing motor benefit after capel tunnel surgery.


Recruitment information / eligibility

Status Terminated
Enrollment 4
Est. completion date August 31, 2020
Est. primary completion date March 21, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - New diagnosis of bell's palsy (diagnosed in the last 30 days) - IF younger than 60 years of age must have complete paralysis on one side of face or both - IF older than 60 years of age paralysis must be present but CAN be incomplete. Exclusion Criteria: - Paralysis associated with any of the fallowing: cancer, tumor, surgery, stroke, or trauma. - Younger than 60 years old with INCOMPLETE paralysis. - Non English speakers - Pacemaker or deep brain stimulator

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Electrical stimulation device (tens unit)
An electrical stimulation device with adjustable voltage. Useful for both Sensory and Subsensory

Locations

Country Name City State
United States Oregon Health and Science University Portland Oregon

Sponsors (1)

Lead Sponsor Collaborator
Oregon Health and Science University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recovery at 3 Months as Measured From Facial Photos With Different Facial Expressions To evaluate for complete recovery, standardized photos of patients at rest, and during movement, will be evaluated by three treatment-blinded otolaryngologists. Total number of patients fully recovered over number of participants will be reported. 3 months
Secondary House Brackmann Scale Determined by three blinded otolaryngologist reviewing facial photos of patients with smile and eye closure. Reported as an average of the three scores. The scales ranges from 1 (normal) to 6 (most severe dysfunction) Baseline, and 3 months
Secondary Patient Reported Quality of Life in Relation to Facial Synkinesis Measured by the Synkinesis Assessment Questionnaire (SAQ) Quality of life is in part measured in this study using the patient reported Synkinesis Assessment Questionnaire (SAQ). The instrument consisting of 10 items asks participants how difficult certain facial activities are. Based on the average score for each domain the test gives a score between 20 (no synkinesis) to 100 (severe synkinesis, all the time). Baseline, 3 months and 6 months
Secondary Patient Reported Global Quality of Life Specific to Facial Paralysis Measured by the validated quality of life patient reported questionnaire Facial Clinimetric Evaluation (FaCE) Scale with a scale from 0 (normal) to 100 (severe dysfunction). The scale encompasses facial movement, facial comfort, oral function, eye comfort, lacrimal control, and social function. Baseline, 3 months and 6 months
Secondary Objective Measurements of Brow Elevation Measuring brow elevation using the MEEI FACE-gram program reported as the millimeters in decreased elevation in comparison to the unaffected side Baseline and in 3 months
Secondary Eye Closure Measuring in millimeters of the eyelids remaining open during maximal eye closure using the MEEI FACE-gram program Baseline and 3 months
Secondary Smile Excursion Measuring oral commissure exclusion using the MEEI FACE-gram program reported as the change in millimeters in the distance between the midline of the lower lip and the oral commissure in comparison between rest and smile Baseline and 3 months
Secondary Facial Symmetry at Rest Measured by facial asymmetry index (FAI) at rest in photos which is calculated as the difference in the distance from the lateral canthus to the oral commissure between the affected and unaffected side. In the scale 0 equals no difference between sides and perfect symmetry. The closer a number is to 0, the higher the symmetry is. Ranges have not been published for this scale. FAI does not have a maximum score. Baseline and 3 months
Secondary Facial Symmetry During Smile Measured by facial asymmetry index (FAI) during smile in photos which is calculated as the difference in the distance from the lateral canthus to the oral commissure between the affected and unaffected side. In the scale 0 equals perfect symmetry and no difference in sides. The closer a number is to 0, the greater the symmetry. Ranges have not been published for this scale. FAI does not have a maximum score. Baseline and 3 months
Secondary Patient Tolerability Measured by a visual analog scale (VAS) which ranged from 0 to 10 where 0 stands for completely comfortable and 10 to very uncomfortable. A questionnaire designed by research team using a Likert's scale was created to measure patient tolerability. 3 months
Secondary Self Reported Subject Adherence Percentage of subjected who reported full adherence, partial adherence and non-adherence confirmed by comparing to the daily diary of use. 3 months
See also
  Status Clinical Trial Phase
Completed NCT05679752 - Effects of Massage Therapy and Facial PNF in Early Bell's Palsy N/A
Terminated NCT03996525 - Electrical Stimulation to Improve Recovery After Peripheral Nerve Injury N/A
Enrolling by invitation NCT02179684 - Surgery or Clincial Follow up, in Patients With Bell' s Palsy N/A
Not yet recruiting NCT06063954 - Two Electroacupuncture Waveforms for Different Severity Groups of Bell Palsy N/A
Completed NCT04807491 - Kabat Technique and Neuromuscular Effect in Patients With Bell's Palsy N/A
Completed NCT03592797 - Effect of Laser Acupuncture Treatment on Chronic Facial Paralysis N/A
Recruiting NCT03781700 - Evaluation of Cortisone Treatment in Children With Acute Facial Nerve Palsy Phase 4
Recruiting NCT04406376 - Do We Need to Taper Down Steroid Therapy for Bell's Palsy Phase 4
Recruiting NCT06029855 - Kabat Rehabilitation Versus Mime Therapy on Facial Disability and Synkinesis in Patients of Bell's Palsy N/A
Recruiting NCT06459830 - Mime Therapy With and Without Neural Mobilization in Bell's Palsy. N/A
Recruiting NCT06340009 - MIME THERAPY vs MOTOR IMAGERY TECHNIQUE in Bell's Palsy N/A
Completed NCT04280120 - Effect of Neural Mobilization in Bells Palsy: A Randomized Controlled Trial N/A
Completed NCT05891106 - AONDA Therapeutic Indication Study I
Completed NCT03974763 - Function and Form Outcomes in Patients With Facial Paralysis
Active, not recruiting NCT05997199 - The Effect Vitamin D on the Recovery Rate of Bell Palsy
Completed NCT04412733 - EFFECTİVENESS OF PULSED ULTRASOUND TREATMENT ON PATIENTS WITH BELL'S PALSY N/A
Recruiting NCT06028191 - Combined Effects of Low Level Laser Therapy and Kabat Technique in Patients With Bell's Palsy N/A
Recruiting NCT05582915 - Screening for Prognostic Biomarkers of Severe Bell's Palsy in Adults
Recruiting NCT05270187 - Multiwave Locked System Laser for Patients With Bell's Palsy. N/A
Recruiting NCT06308250 - Comparative Effects of Mime Therapy and Action Observation Therapy in Bell's Palsy N/A